A Mechanistic Study on the Effect of HTD1801 Versus Placebo on Kidney Function in Patients With Type 2 Diabetes and Chronic Kidney Disease.

NCT07496177 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

75

Enrollment

OTHER

Sponsor class

Conditions

T2DM
CKD

Interventions

DRUG: HTD1801
OTHER: placebo

Sponsor

Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences

Collaborators

[object Object]
[object Object]